Aterian (NASDAQ:ATER) Trading 0.8% Higher – Time to Buy?

Aterian, Inc. (NASDAQ:ATERGet Free Report) shot up 0.8% during mid-day trading on Monday . The company traded as high as $2.58 and last traded at $2.56. 96,263 shares changed hands during trading, an increase of 3% from the average session volume of 93,053 shares. The stock had previously closed at $2.54.

Aterian Stock Down 3.7 %

The company has a market capitalization of $20.66 million, a P/E ratio of -0.90 and a beta of 2.04. The firm’s 50-day moving average price is $2.75 and its 200 day moving average price is $2.80.

Aterian (NASDAQ:ATERGet Free Report) last issued its quarterly earnings data on Monday, November 11th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.30. Aterian had a negative return on equity of 56.01% and a negative net margin of 17.05%. The firm had revenue of $26.24 million during the quarter.

Hedge Funds Weigh In On Aterian

Several institutional investors have recently modified their holdings of the business. XTX Topco Ltd bought a new position in shares of Aterian during the 2nd quarter valued at approximately $59,000. Essex Investment Management Co. LLC purchased a new position in Aterian in the third quarter valued at approximately $102,000. Finally, Jane Street Group LLC bought a new position in Aterian during the third quarter valued at $33,000. 7.02% of the stock is owned by institutional investors.

About Aterian

(Get Free Report)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.

Featured Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.